source
- ObesityWeek 2026 to showcase amylin pathway and emerging weight-loss mechanismsObesityWeek 2026 starts Saturday in Washington, DC, gathering weight-loss experts and biopharma companies with metabolic assets. The meeting will highlight the amylin pathway and other emerging me…
- Clene Nanomedicine partners with Veristat to speed data analysis for ALS drug FDA filingClene Nanomedicine has entered a partnership with clinical research organization Veristat. Under the agreement, Veristat will apply its biostatistics platform to speed the generation and analysis…